(1 - 10 von 11
)
Immunovia's CEO Mats Grahn sells 48,000 Immunovia shares to a Swedish...
news.cision.com
· The buyer is an institutional investor
· The transaction was carried out at a price of SEK
Immunovia, Pressconference, | Financial Hearings
financialhearings.com
Immunovia, Pressconference, December 20th :00 (Europe/Stockholm). Language: English. Speaker: CEO Mats Grahn. Sector: Health care ...
EU grants: Big changes this year in the SME-instrument - MVA
mva.org
Phone: (M) + Linkedin. Print Friendly, PDF & Email Print ... Mats Grahn, CEO at Immunovia which received 4,2 Million Euro for their Phase
Nasdaq Stockholm Welcomes Immunovia to the Main Market
view.news.eu.nasdaq.com
”The admission to trade on the main list of Nasdaq Stockholm is very positive as it strengthens the brand, increases the recognition of the company and confirms the progress and maturity of Immunovia,” said Mats Grahn, CEO and Chairman of the Board of Immunovia. “It is a result of Immunovia's progress ...
sortiert nach Relevanz / Datum